July 07, 2014
The U.S. subsidiary of French pharmaceutical company Sanofi SA has slapped Indian drugmaker Unimark Remedies Ltd. with a lawsuit in Delaware federal court seeking to block the manufacture and sale of a generic version of Multaq, Sanofi's widely prescribed heart rhythm medication.